Stories this month focused on TAVI in low-risk patients, statin safety, the burden of CKM syndrome in the US, and more.
Patients with pulmonary adenocarcinoma consulted the neurology department due to multiple initial symptoms of cerebral ischaemia. Examination of each patient revealed pulmonary embolism, the ...
Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.
The Society of Interventional Radiology (SIR) published new practice guidance for the treatment of chronic pelvic pain in women who suffer from a pelvic venous disorder. The guidance was published ...
The 32nd Actor Awards ceremony at the Shrine Auditorium was always going to be an emotional night, but Sunday turned into a ...
Dr. Frank Brodkey shares key insights from andexanet's development, approval, and real-world clinical trajectory.
Across hospitals and health systems, stroke care sits at the intersection of several pressures leaders know well: rising acuity, uneven access to specialty care, workforce constraints and growing ...
AFTX-201 uses a proprietary capsid to deliver a human BAG3 transgene, aiming to restore cardiac function with lower doses than conventional gene therapies.
Groundbreaking Phase 1/2a clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that the first gene regulation treatment for epilepsy is safe and ...
Newly published research by Cleveland Clinic and Dyania Health demonstrates how a medically trained large language model system can accurately and efficiently screen electronic medical records (EMRs) ...
This report describes a female patient in her 60s with an immune-mediated necrotising myopathy (IMNM) occurring after semaglutide use. She was found to have progressive dysphagia, dysphonia, proximal ...
The Johns Hopkins Armstrong Institute for Patient Safety and Quality leads national VTE prevention efforts through its Venous Thromboembolism (VTE) Collaborative, which aims to advance evidence-based ...